InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $63.54 million. The enterprise value is $98.87 million.
Important Dates
The next estimated earnings date is Tuesday, December 3, 2024, before market open.
Earnings Date | Dec 3, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
InterCure has 45.77 million shares outstanding. The number of shares has increased by 0.82% in one year.
Current Share Class | 45.77M |
Shares Outstanding | 45.77M |
Shares Change (YoY) | +0.82% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 25.04M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 0.35 |
PB Ratio | n/a |
P/TBV Ratio | 1.01 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.37 |
EV / EBITDA | 126.10 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.33.
Current Ratio | 1.78 |
Quick Ratio | 1.15 |
Debt / Equity | 0.33 |
Debt / EBITDA | 19.01 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.61% and return on invested capital (ROIC) is -0.28%.
Return on Equity (ROE) | -13.61% |
Return on Assets (ROA) | -0.23% |
Return on Capital (ROIC) | -0.28% |
Revenue Per Employee | $268,226 |
Profits Per Employee | -$64,553 |
Employee Count | 270 |
Asset Turnover | 0.34 |
Inventory Turnover | 1.48 |
Taxes
In the past 12 months, InterCure has paid $1.43 million in taxes.
Income Tax | 1.43M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.84% in the last 52 weeks. The beta is 0.03, so InterCure's price volatility has been lower than the market average.
Beta (5Y) | 0.03 |
52-Week Price Change | +25.84% |
50-Day Moving Average | 1.72 |
200-Day Moving Average | 2.19 |
Relative Strength Index (RSI) | 36.47 |
Average Volume (20 Days) | 54,292 |
Short Selling Information
The latest short interest is 13,848, so 0.03% of the outstanding shares have been sold short.
Short Interest | 13,848 |
Short Previous Month | 17,825 |
Short % of Shares Out | 0.03% |
Short % of Float | 0.06% |
Short Ratio (days to cover) | 0.69 |
Income Statement
In the last 12 months, InterCure had revenue of $72.42 million and -$17.43 million in losses. Loss per share was -$0.38.
Revenue | 72.42M |
Gross Profit | 20.71M |
Operating Income | -788,824 |
Pretax Income | -15.91M |
Net Income | -17.43M |
EBITDA | 784,043 |
EBIT | -788,824 |
Loss Per Share | -$0.38 |
Full Income Statement Balance Sheet
The company has $5.39 million in cash and $40.06 million in debt, giving a net cash position of -$34.66 million or -$0.76 per share.
Cash & Cash Equivalents | 5.39M |
Total Debt | 40.06M |
Net Cash | -34.66M |
Net Cash Per Share | -$0.76 |
Equity (Book Value) | 122.74M |
Book Value Per Share | 2.56 |
Working Capital | 43.01M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 28.60%, with operating and profit margins of -1.09% and -24.07%.
Gross Margin | 28.60% |
Operating Margin | -1.09% |
Pretax Margin | -22.73% |
Profit Margin | -24.07% |
EBITDA Margin | 1.08% |
EBIT Margin | -1.09% |
FCF Margin | -15.29% |